You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HYPER-CVAD

Showing 1 - 25 of 521
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Lymphoblastic Leukemia Trial in Tampa (Hyper CVAD Protocol (Standard of Care Multi-Agent Chemotherapy), Calaspargase

Recruiting
  • Acute Lymphoblastic Leukemia
  • Hyper CVAD Protocol (Standard of Care Multi-Agent Chemotherapy)
  • +2 more
  • Tampa, Florida
    Moffitt Cancer Center
Oct 12, 2022

Contiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Stage I Adult

Completed
  • Contiguous Stage II Adult Lymphoblastic Lymphoma
  • +5 more
  • Sacramento, California
    University of California Davis
Mar 8, 2022

Leukemia Trial in Portland (cyclophosphamide, cytarabine, dexamethasone)

Terminated
Has Results
  • Leukemia
  • Portland, Oregon
    OHSU Knight Cancer Institute
Dec 13, 2022

Leukemia, Acute Lymphoblastic Leukemia Trial in Houston (Rituximab, Cyclophosphamide (CTX), Doxorubicin)

Completed
Has Results
  • Leukemia
  • Acute Lymphoblastic Leukemia
  • Houston, Texas
    UT MD Anderson Cancer Center
Dec 1, 2020

Mantle Cell Lymphoma Trial in Madison (modified Hyper-CVAD)

Completed
Has Results
  • Mantle Cell Lymphoma
  • modified Hyper-CVAD
  • Madison, Wisconsin
    UWCCC
Dec 11, 2019

T Acute Lymphoblastic Leukemia, T Lymphoblastic Lymphoma Trial in Houston (Cyclophosphamide, Cytarabine, Dexamethasone)

Recruiting
  • T Acute Lymphoblastic Leukemia
  • T Lymphoblastic Lymphoma
  • Houston, Texas
    M D Anderson Cancer Center
Jan 11, 2023

Acute Lymphocytic Leukemia, Adult B-Cell, BCR-ABL1 Fusion Protein Expression Trial in Nanjing (Flumatinib)

Recruiting
  • Acute Lymphocytic Leukemia, Adult B-Cell
  • BCR-ABL1 Fusion Protein Expression
  • Nanjing, Jiangsu, China
  • +1 more
Mar 22, 2022

Blastoid Variant Mantle Cell Lymphoma, CD20 Positive, Mantle Cell Lymphoma Trial in Houston (drug, other, biological)

Active, not recruiting
  • Blastoid Variant Mantle Cell Lymphoma
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 8, 2022

Philadelphia-Positive ALL Trial in Suzhou (Olverembatinib combined with chemo)

Not yet recruiting
  • Philadelphia-Positive ALL
  • Olverembatinib combined with chemotherapy
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University, Jiangsu Ins
Jul 17, 2022

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Adult Acute Lymphoblastic

Recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 31, 2022

Waldenstrom's Macroglobulinemia Trial in Houston (Bortezomib, Rituximab, Valacyclovir)

Active, not recruiting
Has Results
  • Waldenstrom's Macroglobulinemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 5, 2022

Acute Lymphoblastic Leukemia, Adult Acute Lymphoblastic Leukemia in Complete Remission, Burkitt Leukemia Trial in Houston (drug,

Completed
Has Results
  • Acute Lymphoblastic Leukemia
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Apr 6, 2021

Precursor Cell Lymphoblastic Leukemia-Lymphoma, Philadelphia-Positive Acute Lymphoblastic Leukemia, ALL, Adult Trial in Xi'an

Recruiting
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma
  • +2 more
  • dasatinib plus consolidation chemotherapy with vincristine and prednisone
  • dasatinib plus consolidation chemotherapy with high-dose methotrexate and cytarabine
  • Xi'an, Shaanxi, China
    First Affiliated Hospital of Xian Jiaotong University
Sep 29, 2021

Acute Lymphoblastic Leukemia in Remission, B Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Philadelphia

Terminated
Has Results
  • Acute Lymphoblastic Leukemia in Remission
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 18, 2021

Acute Lymphoblastic Leukemia, Adult, Ph+ ALL, Newly Diagnosed Trial in Czechia (Ponatinib 15 MG Oral Tablet)

Active, not recruiting
  • Acute Lymphoblastic Leukemia, Adult
  • +2 more
  • Ponatinib 15 MG Oral Tablet
  • Brno, Czechia
  • +6 more
Nov 30, 2022

B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma Trial in Houston (biological, drug, other)

Recruiting
  • B Acute Lymphoblastic Leukemia
  • B Lymphoblastic Lymphoma
  • Blinatumomab
  • +12 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 21, 2021

Blastic Plasmacytoid Dendritic Cell Tumor Trial in Houston (Cyclophosphamide, Cytarabine, Dexamethasone)

Recruiting
  • Blastic Plasmacytoid Dendritic Cell Neoplasm
  • Houston, Texas
    M D Anderson Cancer Center
Nov 30, 2021

Leukemia, Acute Lymphocytic Leukemia Trial in Houston (Everolimus (RAD001), Cyclophosphamide, Vincristine)

Completed
Has Results
  • Leukemia
  • Acute Lymphocytic Leukemia
  • Everolimus (RAD001)
  • +9 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 5, 2019

Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b) Trial

Completed
  • Adult Acute Megakaryoblastic Leukemia (M7)
  • +13 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Feb 2, 2023

B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 Trial in Israel, United States (Blinatumomab,

Recruiting
  • B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
  • Blinatumomab
  • +10 more
  • Anchorage, Alaska
  • +152 more
Aug 11, 2022

Burkitt's Lymphoma, Burkitt'S-like Lymphoma Trial in Houston (Rituximab, Cyclophosphamide, Doxorubicin)

Completed
Has Results
  • Burkitt's Lymphoma
  • Burkitt'S-like Lymphoma
  • Houston, Texas
    The University of Texas M. D. Anderson Cancer Center
Apr 18, 2018

Catheter Occlusion, Thrombosis Trial in Worldwide (CUSA-081, Placebo, Alteplase)

Recruiting
  • Catheter Occlusion
  • Thrombosis
  • Little Rock, Arkansas
  • +76 more
Mar 29, 2022

Healthy Trial in Abbottabad (Left Nostril Breathing, Conventional)

Not yet recruiting
  • Healthy
  • Left Nostril Breathing
  • Conventional
  • Abbottābād, KPK, Pakistan
    Women Instritute of Rehabilitation Sciences, Jinnah College of N
May 26, 2023

Tooth Whitening Trial (Elgydium Clinic Sensileave Gel (V063B - DP3003))

Not yet recruiting
  • Tooth Whitening
  • Elgydium Clinic Sensileave Gel (V063B - DP3003)
  • (no location specified)
Mar 27, 2023

Central Venous Catheter Thrombosis, Central Venous Catheter Related Bloodstream Infection, Catheter Complications Trial in

Recruiting
  • Central Venous Catheter Thrombosis
  • +7 more
  • 4% EDTA
  • Saline
  • New Westminster, British Columbia, Canada
  • +4 more
Jul 5, 2022